Evidence map›Paper›PMID 37835036›Full record

ArticleJournal of clinical medicine2023

Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease.

Gesine Meyer, Madeleine Gruendl, Irina Chifu, Stefanie Hahner, Johanna Werner, Johannes Weiß, Tina Kienitz, Marcus Quinkler, Klaus Badenhoop, Eva Herrmann and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Gesine MeyerDivision of Endocrinology, Medical Clinic 1, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0001-5639-4537
Madeleine GruendlDivision of Endocrinology, Medical Clinic 1, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.
Irina ChifuEndocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, 97080 Wuerzburg, Germany.
Stefanie HahnerEndocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, 97080 Wuerzburg, Germany.
Johanna WernerEndocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, 97080 Wuerzburg, Germany.
Johannes WeißDivision of Hepatology, Department of Medicine II, University Hospital Wuerzburg, 97080 Wuerzburg, Germany.
Tina KienitzEndocrinology in Charlottenburg, 10627 Berlin, Germany.
Marcus QuinklerEndocrinology in Charlottenburg, 10627 Berlin, Germany.
Klaus BadenhoopDivision of Endocrinology, Medical Clinic 1, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.
Eva HerrmannInstitut for Biostatistics and Mathematic Modelling, Goethe University Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0002-0662-6675
Mireen Friedrich-RustDivision of Hepatology, Medical Clinic 1, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.
Joerg BojungaDivision of Endocrinology, Medical Clinic 1, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, Germany.
Goethe University Frankfurt · DEUniversitätsklinikum Würzburg · DE

Funding

Deutsche Forschungsgemeinschaft 314061271:CRC/Transregio 205/1Else Kröner-Fresenius-Stiftung RISE
6 · The paper itself

Abstract

Glucocorticoid excess is a known risk factor for non-alcoholic fatty liver disease (NAFLD). Our objective was to analyse the impact of glucocorticoid replacement therapy on the development of NAFLD and NAFLD-related fibrosis and, therefore, on cardiovascular as well as hepatic morbidity in patients with adrenal insufficiency. Two hundred and fifteen individuals with primary (

Indexed as

adrenal insufficiencycardiometabolic riskelastographyglucocorticoid replacementhepatic fibrosishepatic steatosisnon-alcoholic fatty liver disease

Identifiers

PMID37835036
PMCPMC10573835
OpenAlexW4387458136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.